Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 06, 2022, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Entacapone Tablets USP, 200 mg".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 06, 2022, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Entacapone Tablets USP, 200 mg".